• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对于因酒精性肝病入院的患者,酒精使用障碍的住院筛查、简短干预及转诊治疗在实际中并未普遍实施,但可减少酒精性肝炎的再入院率。

Inpatient Screening, Brief Intervention, and Referral to Treatment for Alcohol Use Disorder in Patients Admitted with Alcohol-associated Liver Disease Is Not Universally Implemented in Practice, But Can Reduce Readmissions for Alcohol-associated Hepatitis.

作者信息

Wang Dennis, Puglia Marco

机构信息

McMaster University Adult Gastroenterology Residency Program, Hamilton, ON, Canada.

Division of Gastroenterology, Department of Medicine, McMaster University, Hamilton, ON, Canada.

出版信息

J Can Assoc Gastroenterol. 2023 Nov 30;7(2):169-176. doi: 10.1093/jcag/gwad048. eCollection 2024 Apr.

DOI:10.1093/jcag/gwad048
PMID:38596805
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10999764/
Abstract

INTRODUCTION

The management of alcohol-related liver disease requires a multidisciplinary approach to treat alcohol use disorder. We aimed to determine the proportion of actively drinking patients admitted for alcohol-associated hepatitis (AAH) or decompensated alcohol-related cirrhosis (DARLC) who were offered or underwent screening, brief intervention, and referral to treatment (SBIRT) for alcohol use disorder during admission and if inpatient SBIRT is associated with reduced readmissions for alcohol-related liver disease.

METHODS

We conducted a retrospective cohort study of actively drinking patients admitted to our institution from January 2017 to December 2021 with AAH or DARLC. Logistic regression was used to identify factors, such as conducting SBIRT, that were associated with 30-day and 90-day readmissions for recurrent AAH or DARLC.

RESULTS

There were 120 AAH admissions (mean age 47.7 ± 13.6 years), and 177 DARLC admissions (mean age 58.2 ± 9.5 years). SBIRT was conducted in only 51.7% of AAH admissions, and 23.7% of DARLC admissions. For AAH, conducting SBIRT was associated with significantly reduced 30-day (OR 0.098, = 0.001, 95% CI 0.024-0.408) and 90-day (OR 0.166, = 0.003, 95% CI 0.052-0.534) readmissions. For DARLC, there was no association between conducting SBIRT and 30-day or 90-day readmissions.

CONCLUSION

SBIRT was conducted with actively drinking patients in only 51.7% of AAH admissions and 23.7% of DARLC admissions. Patients admitted for AAH who received inpatient SBIRT had decreased 30-day and 90-day readmission rates for AAH or DARLC.

摘要

引言

酒精性肝病的管理需要多学科方法来治疗酒精使用障碍。我们旨在确定因酒精性肝炎(AAH)或失代偿性酒精性肝硬化(DARLC)入院且仍在积极饮酒的患者在住院期间接受筛查、简短干预及转介治疗(SBIRT)以治疗酒精使用障碍的比例,以及住院SBIRT是否与酒精性肝病再入院率降低相关。

方法

我们对2017年1月至2021年12月期间因AAH或DARLC入住我院且仍在积极饮酒的患者进行了一项回顾性队列研究。采用逻辑回归分析来确定与复发性AAH或DARLC的30天和90天再入院相关的因素,如进行SBIRT。

结果

有120例AAH入院患者(平均年龄47.7±13.6岁),177例DARLC入院患者(平均年龄58.2±9.5岁)。仅51.7%的AAH入院患者和23.7%的DARLC入院患者接受了SBIRT。对于AAH,进行SBIRT与30天(比值比0.098,P = 0.001,95%置信区间0.024 - 0.408)和90天(比值比0.166,P = 0.003,95%置信区间0.052 - 0.534)再入院率显著降低相关。对于DARLC,进行SBIRT与30天或90天再入院之间无关联。

结论

仅51.7%的AAH入院患者和23.7%的DARLC入院患者接受了SBIRT。接受住院SBIRT的AAH入院患者的AAH或DARLC 30天和90天再入院率有所降低。

相似文献

1
Inpatient Screening, Brief Intervention, and Referral to Treatment for Alcohol Use Disorder in Patients Admitted with Alcohol-associated Liver Disease Is Not Universally Implemented in Practice, But Can Reduce Readmissions for Alcohol-associated Hepatitis.对于因酒精性肝病入院的患者,酒精使用障碍的住院筛查、简短干预及转诊治疗在实际中并未普遍实施,但可减少酒精性肝炎的再入院率。
J Can Assoc Gastroenterol. 2023 Nov 30;7(2):169-176. doi: 10.1093/jcag/gwad048. eCollection 2024 Apr.
2
A Randomized Controlled Trial of an Integrated Alcohol Reduction Intervention in Patients With Hepatitis C Infection.一项针对丙型肝炎感染患者的综合酒精减少干预的随机对照试验。
Hepatology. 2020 Jun;71(6):1894-1909. doi: 10.1002/hep.31058. Epub 2020 Mar 24.
3
Utilization of Nurse-Administered Screening, Brief Intervention, and Referral to Treatment in a Brief Psychiatric Inpatient Unit.在简短精神科住院病房中利用护士主导的筛查、简短干预和转介治疗。
J Addict Nurs. 2023;34(2):131-134. doi: 10.1097/JAN.0000000000000525.
4
The effect of inpatient addiction screening and intervention on readmissions.住院成瘾筛查和干预对再入院的影响。
Appl Nurs Res. 2022 Jun;65:151573. doi: 10.1016/j.apnr.2022.151573. Epub 2022 Mar 19.
5
Screening, brief intervention, and referral to treatment for adolescent alcohol use in Canadian pediatric emergency departments: a national survey of pediatric emergency physicians.加拿大儿科急诊医生对青少年酒精使用的筛查、简短干预和转介治疗:一项全国性调查。
CJEM. 2019 Jan;21(1):97-102. doi: 10.1017/cem.2018.390. Epub 2018 Jun 14.
6
Successful Implementation of an Alcohol Screening, Brief Intervention, and Referral to Treatment Program.酒精筛查、简短干预及转介治疗项目的成功实施
J Trauma Nurs. 2018 May/Jun;25(3):196-200. doi: 10.1097/JTN.0000000000000368.
7
Impact of a computer-assisted Screening, Brief Intervention and Referral to Treatment on reducing alcohol consumption among patients with hazardous drinking disorder in hospital emergency departments. The randomized BREVALCO trial.计算机辅助筛查、简短干预及转介治疗对减少医院急诊科危险饮酒障碍患者酒精摄入量的影响。随机BREVALCO试验。
Drug Alcohol Depend. 2016 Aug 1;165:236-44. doi: 10.1016/j.drugalcdep.2016.06.018. Epub 2016 Jun 25.
8
Hospitalized patients' acceptability of nurse-delivered screening, brief intervention, and referral to treatment.住院患者对护士提供的筛查、简短干预和转介治疗的接受程度。
Alcohol Clin Exp Res. 2012 Apr;36(4):725-31. doi: 10.1111/j.1530-0277.2011.01651.x. Epub 2012 Jan 17.
9
A randomized study of the use of screening, brief intervention, and referral to treatment (SBIRT) for drug and alcohol use with jail inmates.一项针对监狱囚犯药物和酒精使用情况,采用筛查、简短干预及转介治疗(SBIRT)的随机研究。
J Subst Abuse Treat. 2017 Mar;74:54-64. doi: 10.1016/j.jsat.2016.12.011. Epub 2016 Dec 30.
10
SBIRT (Screening, Brief Intervention, and Referral to Treatment) Among Trauma Patients: A Review of the Inpatient Process and Patient Experience.创伤患者中的SBIRT(筛查、简短干预和转诊治疗):住院流程与患者体验综述
J Trauma Nurs. 2017 Jan/Feb;24(1):42-45. doi: 10.1097/JTN.0000000000000261.

引用本文的文献

1
Treatment of alcohol use disorder in alcohol-associated liver disease: A meta-analysis.酒精相关性肝病中酒精使用障碍的治疗:一项荟萃分析。
Hepatol Commun. 2025 Apr 30;9(5). doi: 10.1097/HC9.0000000000000686. eCollection 2025 May 1.
2
Demographic and clinical characteristics associated with utilization of alcohol use disorder treatment in a multicenter study of patients with alcohol-associated cirrhosis.在一项针对酒精性肝硬化患者的多中心研究中,与酒精使用障碍治疗利用情况相关的人口统计学和临床特征。
Alcohol Clin Exp Res (Hoboken). 2025 Jan;49(1):244-255. doi: 10.1111/acer.15500. Epub 2024 Dec 4.

本文引用的文献

1
The Effect of SBIRT on Harmful Alcohol Consumption in the Community Health Centers of Shanghai, China: A Randomized Controlled Study.《SBIRT 对中国上海社区卫生中心有害酒精消费的影响:一项随机对照研究》
Alcohol Alcohol. 2022 Nov 11;57(6):742-748. doi: 10.1093/alcalc/agac030.
2
Prevalence, co-morbidities, and in-hospital mortality of patients hospitalized with alcohol-associated hepatitis in the United States from 2015 to 2019.2015 年至 2019 年期间,美国因酒精相关性肝炎住院的患者的患病率、合并症和住院死亡率。
Alcohol Clin Exp Res. 2022 Aug;46(8):1472-1481. doi: 10.1111/acer.14896. Epub 2022 Jul 12.
3
The effect of inpatient addiction screening and intervention on readmissions.住院成瘾筛查和干预对再入院的影响。
Appl Nurs Res. 2022 Jun;65:151573. doi: 10.1016/j.apnr.2022.151573. Epub 2022 Mar 19.
4
Identifying Alcohol Use Disorder in Patients With Cirrhosis Reduces 30-Days Readmission Rate.识别肝硬化患者的酒精使用障碍可降低 30 天再入院率。
Alcohol Alcohol. 2022 Sep 10;57(5):576-580. doi: 10.1093/alcalc/agac015.
5
Patient- and provider-level factors that underlie alcohol use disorder treatment offer and acceptance in veterans with cirrhosis.患者和提供者层面的因素是导致肝硬化退伍军人接受和提供酒精使用障碍治疗的基础。
Alcohol Clin Exp Res. 2022 May;46(5):809-814. doi: 10.1111/acer.14809. Epub 2022 Mar 28.
6
Clinicians' perspectives and perceived barriers to caring for patients with alcohol use disorder and cirrhosis.临床医生对酒精使用障碍和肝硬化患者的护理的看法和感知障碍。
Addict Sci Clin Pract. 2022 Feb 9;17(1):9. doi: 10.1186/s13722-022-00292-8.
7
Trends of alcoholic liver cirrhosis readmissions from 2010 to 2018: Rates and healthcare burden associated with readmissions.2010年至2018年酒精性肝硬化再入院趋势:再入院率及相关医疗负担
World J Hepatol. 2021 Dec 27;13(12):2128-2136. doi: 10.4254/wjh.v13.i12.2128.
8
Declining Inpatient Mortality Despite Increasing Thirty-Day Readmissions of Alcoholic Hepatitis in the United States From 2010 to 2018.2010年至2018年美国酒精性肝炎患者30天再入院率上升但住院死亡率下降
Gastroenterology Res. 2021 Dec;14(6):334-339. doi: 10.14740/gr1473. Epub 2021 Nov 29.
9
Barriers to the management of alcohol use disorder and alcohol-associated liver disease: strategies to implement integrated care models.酒精使用障碍和酒精相关肝病管理障碍:实施综合护理模式的策略。
Lancet Gastroenterol Hepatol. 2022 Feb;7(2):186-195. doi: 10.1016/S2468-1253(21)00191-6.
10
Results of Early Transplantation for Alcohol-Related Cirrhosis: Integrated Addiction Treatment With Low Rate of Relapse.酒精性肝硬化早期移植的结果:整合成瘾治疗,复发率低。
Gastroenterology. 2021 Dec;161(6):1896-1906.e2. doi: 10.1053/j.gastro.2021.08.004. Epub 2021 Aug 8.